UAB: Comprehensive Cancer Center

Albert F. LoBuglio, M.D.
Associate Director for Clinical Research

Albert F. LoBuglio, M.D., served as the Director of the UAB Comprehensive Cancer Center from March 1983 until July 2004. However, he continues to serve as a faculty member and Associate Director for Clinical Research, as well as advisor to the current director. In 2005, the University of Alabama Board of Trustees once again recognized Dr. LoBuglio’s contributions by bestowing on him the title of Distinguished Professor and Director Emeritus to honor his role as a respected physician, researcher and administrator.

Dr. LoBuglio is recognized as an international leader in the field of tumor immunology, particularly for his work in developing monoclonal antibodies for cancer therapy. In 1993 his accomplishments were recognized by the UAB President’s Medal, and in 1994 he was the first to be selected by the University of Alabama Board of Trustees to hold the Evalina B. Spencer Chair in Oncology. Because of his achievements as a physician-scientist and his outstanding leadership of the Cancer Center, he received the university’s Distinguished Faculty Lecturer Award in 1995, the highest honor bestowed by his peers at the UAB Academic Health Center. Dr. LoBuglio also served as Associate Dean of the UAB School of Medicine from 1996-2000.

Prior to his recruitment to UAB, Dr. LoBuglio had served since 1978 as Professor of Medicine; Director, Division of Hematology-Oncology; and Director of the Simpson Memorial Research Institute at the University of Michigan Medical Center in Ann Arbor. Prior to that, he was a Professor of Medicine at Ohio State University’s College of Medicine and Deputy Director of Ohio State’s Comprehensive Cancer Center in Columbus.

A native of Buffalo, New York, Dr. LoBuglio is an alumnus of Canisius College and a cum laude graduate from Georgetown University Medical School. He completed his internship and residency at Presbyterian University Hospital in Pittsburgh. He previously held research and clinical fellowships at Boston City Hospital’s Thorndike Memorial Laboratory and Harvard Medical School.